Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Fibrin Sealants Market Growth From $1.27 Billion In 2026 To $1.73 Billion By 2030 At A CAGR Of 8%#_x000D_
The fibrin sealants market has shown robust growth over recent years. It is projected to expand from $1.17 billion in 2025 to $1.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.4%. The growth observed in prior periods stems from factors such as the constrained supply of recombinant and synthetic sealants, a reliance on sealants derived from autologous and bovine sources, an uptick in surgical procedures, increasing awareness regarding hemostasis, and the broader integration of fibrin sealants in general surgical practices._x000D_
_x000D_
The fibrin sealants market size is anticipated to undergo significant expansion in the coming years, reaching $1.73 billion in 2030 with a compound annual growth rate (CAGR) of 8.0%. This projected growth during the forecast period is due to advancements in recombinant fibrin production, the increasing prevalence of minimally invasive and robotic surgeries, rising demand in cardiovascular and orthopedic procedures, an increase in regulatory approvals and quality certifications, and the development of bioabsorbable and multifunctional sealants. Major trends for the forecast period include the rising adoption of fibrin sealants in minimally invasive surgeries, an increased use of recombinant and synthetic sealants, the expansion of orthopedic and cardiovascular surgeries, a growing emphasis on blood conservation and hemostasis, and a rising preference for bioabsorbable and patch-based sealants._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Fibrin Sealants Market Opportunity Drivers: What’s Unlocking New Revenue Potential?#_x000D_
The growing volume of cosmetic surgeries is projected to boost the fibrin sealants market in the coming years. Cosmetic surgeries are medical procedures primarily focused on enhancing or altering an individual’s appearance. The rise in these surgeries is attributed to increased societal emphasis on aesthetics, advancements in surgical techniques, and the expanding availability of minimally invasive procedures. Fibrin sealants play a crucial role in cosmetic surgeries by promoting faster wound healing, reducing bleeding, and minimizing scarring, thereby enhancing surgical outcomes and patient recovery. For instance, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons, liposuction remained the top plastic surgery procedure in 2023, with 347,782 procedures performed, representing a 7% increase from 2022, while tummy tucks also saw a 5% rise, with 170,110 procedures performed. Therefore, the increasing number of cosmetic surgeries is a key driver for the fibrin sealants market._x000D_
_x000D_
#Fibrin Sealants Market Segment Trends And Revenue Contributors#_x000D_
The fibrin sealants market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Liquid, Patch, Powder_x000D_
2) By Technology: Autologous Donation, Viral Inactivation, Recombinant Production, Other Technologies_x000D_
3) By Application: General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery, Urological Surgeries, Ophthalmic Surgeries, Transplant Surgery, Other Applications_x000D_
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Liquid: Bovine-Derived Liquid Sealants, Human-Derived Liquid Sealants, Synthetic Liquid Sealants, Recombinant Fibrin Sealants _x000D_
2) By Patch: Bovine-Derived Fibrin Patches, Human-Derived Fibrin Patches, Synthetic Fibrin Patches, Bioabsorbable Fibrin Patches _x000D_
3) By Powder: Bovine-Derived Fibrin Powder, Human-Derived Fibrin Powder, Synthetic Fibrin Powder, Recombinant Fibrin Powder _x000D_
_x000D_
#Fibrin Sealants Market Innovation Trends Shaping Future Development#_x000D_
Leading companies in the Fibrin Sealants market are concentrating on creating innovative solutions, including fibrin sealant, to enhance hemostasis, reduce surgical complications, improve wound healing outcomes, and optimize patient recovery across diverse surgical procedures. Fibrin sealants, also known as fibrin glues, are biological adhesive products derived from human or animal blood components that emulate the final stages of the natural blood clotting process. For instance, in October 2024, Grifols S.A., a global biopharmaceutical company based in Spain, received FDA approval for its fibrin sealant solution designed to treat surgical bleeding in pediatric patients. This product is intended to bolster surgical safety, improve clot formation at the wound site, and decrease the risk of postoperative complications, offering a specialized option for pediatric surgeries where precise hemostasis is crucial. The solution’s versatility and efficiency further allow its use across various surgical settings compared to conventional approaches._x000D_
_x000D_
#Fibrin Sealants Market Leading Companies And Competitive Benchmarking#_x000D_
Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc _x000D_
_x000D_
#View The Full Fibrin Sealants Market Report:#_x000D_
_x000D_
#Fibrin Sealants Market Largest Region By Revenue And Market Share#_x000D_
North America was the largest region in the fibrin sealants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibrin sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
